Logically for a dose escalation stage focused on safety they would be assessing pre and post treatment.
Ann: Expanded Heart Protection Discovery for Zantrene, page-232
-
- There are more pages in this discussion • 155 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.48 |
Change
0.015(1.02%) |
Mkt cap ! $252.2M | |||
| Open | High | Low | Value | Volume |
| $1.49 | $1.49 | $1.47 | $27.09K | 18.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7418 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.48 | 2073 | 2 |
View Market Depth
| Last trade - 10.45am 14/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |